MM

Madhan Mohan Kadaverugu

Active Director Managing Director DIN 11377599
DIN 11377599 First appointment Nov 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Madhan Mohan Kadaverugu

Data last updated:

Madhan Mohan Kadaverugu is a Managing Director at Tavaka Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11377599
Primary Designation Managing Director
Industry Pharma
First Appointment 11 Nov 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director11 Nov 20252025Active

Board colleagues of Madhan Mohan Kadaverugu

NameDINCompanyDesignation
Swarnalatha Kadavergu11377600Tavaka Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Tavaka Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Madhan Mohan Kadaverugu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madhan Mohan Kadaverugu

Madhan Mohan Kadaverugu currently holds 1 directorship: Tavaka Pharmaceuticals Private Limited (Managing Director, since 11 Nov 2025).

Madhan Mohan Kadaverugu was first appointed on 11 Nov 2025 as Managing Director at Tavaka Pharmaceuticals Private Limited.

The current boards of Madhan Mohan Kadaverugu's companies include Swarnalatha Kadavergu (Tavaka Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available